This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
(Health Catalyst) , a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited (Lumeon) , a digitalhealth company with operations in the U.S. Originally announced August 8th, 2024
Health Catalyst, Inc., a provider of data analytics technology and services for healthcare organizations, has announced the successful acquisition of Lumeon Limited , a digitalhealth company with a significant presence in both the United States and the United Kingdom.
Providence, a 52-hospital health system based in Renton, Washington, views digital innovation as an important vehicle to overcoming industrywide challenges and transforming care delivery for the betterment of the communities it serves. of remote encounters escalate to Providence clinicians.
Omadas Enhanced GLP-1 Care Track, announced in 2024, was designed to support members throughout GLP-1 use and afterward leveraging behavioral support, weight monitoring, nutrition, medication management education, and tailored exercise and movement plans to optimize outcomes. Read the full abstract on Omadas website.
The following is a guest article by Mike Pattwell, Principal Business Advisor, Value Based Care at Edifecs Consumers are at the heart of healthcare — their fears are forcing healthcare innovators to shift priorities to deliver consumer-centric digitalhealth offerings. Data input means data output.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content